文献速递产科母胎医学

有早产史且无症状宫颈缩短者的产前皮质类固醇最佳暴露

Optimal antenatal corticosteroid exposure in women with history of preterm birth and asymptomatic short cervical length.
PubMed 文献 · Am J Obstet Gynecol MFM · 2021-04-06

本研究为回顾性队列研究,纳入2011至2016年间有自发早产史且单胎妊娠的287名女性,比较因无症状宫颈缩短与因早产症状接受产前皮质类固醇者的最佳暴露(给药至分娩≤7天)。结果显示宫颈缩短组最佳暴露率显著更低(1.2% vs 19.0%),且足月分娩时暴露比例更高(43.2% vs 33.4%),<34周早产前7天内接受初始或补救疗程的比例也更低(42.9% vs 76.9%)。

要点

  • 无症状宫颈缩短者接受产前皮质类固醇的最佳暴露率仅1.2%,远低于早产症状者的19.0%。
  • 宫颈缩短组足月分娩时暴露比例更高(43.2% vs 33.4%),提示过度暴露。
  • 宫颈缩短组<34周早产前7天内接受初始或补救疗程的比例更低(42.9% vs 76.9%)。

核心结论

  • 有早产史女性因无症状宫颈缩短接受产前皮质类固醇,其最佳暴露率显著低于因早产症状用药者。
  • 数据挑战仅以宫颈长度监测作为产前皮质类固醇给药时机指征的做法。

研究设计与样本

  • 回顾性队列研究,纳入2011至2016年大型学术三级医疗中心有既往自发早产史且单胎妊娠并接受系列宫颈长度评估的女性。
  • 共287名女性纳入分析,其中166名(57.8%)因无症状宫颈缩短用药,121名(42.2%)因早产症状用药。
  • 主要结局为最佳产前皮质类固醇暴露,定义为给药至分娩时间≤7天。
  • 采用泊松回归计算发病率比(IRR)和置信区间(CI),调整种族、最早既往早产孕周和当前宫颈环扎。

临床怎么用

  • 对于有早产史的无症状宫颈缩短女性,应审慎评估以宫颈长度监测作为产前皮质类固醇给药时机的策略。
  • 临床决策需权衡产前皮质类固醇的最佳暴露与足月分娩时的不必要暴露。

局限性

  • 回顾性队列设计可能存在选择偏倚和混杂。
  • 研究仅纳入单一学术三级医疗中心2011至2016年数据,外推性受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A proposed benefit of cervical length assessment after 24 weeks' gestation in women with a history of preterm birth is to aid in the timing of antenatal corticosteroids in otherwise asymptomatic women. OBJECTIVE: We sought to investigate whether the use of an ultrasonographic short cervical length as an indication for antenatal corticosteroids in asymptomatic women results in optimal exposure compared with women receiving antenatal corticosteroids for preterm labor symptoms. STUDY DESIGN: Retrospective cohort study of all women with a previous spontaneous preterm birth and a singleton gestation who underwent serial cervical length assessment at a large academic tertiary medical center from 2011 to 2016. Patients were included in the analysis if they received antenatal corticosteroids for either an asymptomatic short cervical length or symptoms of preterm labor. The primary outcome was optimal antenatal corticosteroids exposure (latency to delivery of ≤7 days). PROPOSED CHANGE IN RESULTS: Poisson regression with robust error variance was used to calculate incidence rate ratios (IRR) and confidence intervals (CI) for primary and secondary outcomes adjusting for primary and secondary outcomes adjusting for race, earliest previous preterm birth, and current cerclage. RESULTS: There were 287 women meeting inclusion criteria, among whom 166 (57.8%) received antenatal corticosteroids for a short cervical length and 121 (42.2%) for preterm labor symptoms. Women who received antenatal corticosteroids for a short cervical length were less likely to have optimal exposure (1.2% vs 19.0%; incidence rate ratios, 0.06; confidence interval, 0.02-0.27) compared with women with preterm labor symptoms. They were also more likely to have exposure with eventual term delivery (43.2% vs 33.4%; incidence rate ratios, 1.6; confidence interval, 1.2-2.0). Importantly, women who received antenatal corticosteroids for a short cervical length were significantly less likely to receive either an initial or rescue antenatal corticosteroids course within 7 days of a preterm delivery of less than 34 weeks' gestation (42.9% vs 76.9%; incidence rate ratios, 0.52; confidence interval, 0.35-0.75). CONCLUSION: Women with a previous preterm birth who receive antenatal corticosteroids for an asymptomatic short cervical length are less likely to have optimal exposure than women with symptoms of preterm labor. These data challenge the practice of cervical length surveillance for the sole indication of timing antenatal corticosteroids administration.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Finneran MM, Waickman C, Shellhaas C, et al. Optimal antenatal corticosteroid exposure in women with history of preterm birth and asymptomatic short cervical length. Am J Obstet Gynecol MFM. 2021. PMID: 33836305. doi:10.1016/j.ajogmf.2021.100371

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。